Mealey's (October 3, 2022, 12:33 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on Oct. 3 called for the views of the U.S. solicitor general in a patent dispute over Teva Pharmaceuticals USA Inc.’s launch of generic carvedilol, the active ingredient in the congestive heart failure (CHF) drug “Coreg.”...